@oricpharma.com
Overcoming resistance
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Welcome to ORIC Pharmaceuticals, a brand dedicated to improving patients' lives by targeting resistance mechanisms in cancer. Our bold vision is to discover, develop, and commercialize innovative therapies that address cancer resistance, making existing treatments work better and longer. Despite advancements in oncology drug development, therapeutic resistance and relapse still limit the efficacy and duration of clinical benefit.
At ORIC, our resistance platform focuses on three areas: innate resistance, acquired resistance, and bypass resistance. These encompass unaddressed oncogenic drivers, induced or enriched drivers in response to treatment, and compensatory signaling pathways activated after treatment. We are currently enrolling patients in three phase 1 clinical trials: ORIC-533 for multiple myeloma, ORIC-114 for EGFR/HER2 cancers, and ORIC-944 for prostate cancer.
Join us on this journey to revolutionize cancer treatment. Motivated by a shared purpose, our collaborative and open culture empowers each team member to do cutting-edge work on therapies for treatment-resistant cancers. Stay informed with our latest news and updates, and reach out to us at info@oricpharma.
com or (650) 388-5600 for more information. Together, we can make a difference in the fight against cancer
Company Type
Public Company
Company Size
51-200
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories